North America flow cytometry market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.5% in the forecast period of 2022 to 2029 and is expected to reach USD 6,217.87 million by 2029 from USD 2,438.92 million in 2021.
North America Flow Cytometry Market Regional Analysis/Insights
The North America flow cytometry market is analysed, and market size insights and trends are provided by country, product, technology, application, end user and distribution channel referenced above.
The countries covered in the North America flow cytometry market are
Ø Canada and
The U.S. is expected to dominate the North America flow cytometry market due to the surging incidence rate of diseases such as cancer and HIV amongst the population, which is boosting the demand for flow cytometry for diagnostic applications.
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
COVID-19 Impact on the North America Flow Cytometry Market
COVID-19 has positively affected the market due to disease diagnosis and research purposes which raises the demand for flow cytometry during this period.
- In June 2021, Thermo Fisher Scientific Inc. launched the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera. This has enhanced the company's flow cytometry portfolio
Competitive Landscape and North America Flow Cytometry Market Share Analysis
Some of the major players operating in the flow cytometry market are
· Thermo Fisher Scientific Inc.,
· Agilent Technologies, Inc.,
· Luminex Corporation (now subsidiary of DiaSorin S.p.A.),
· Nexcelom Bioscience LLC,
· Bio-Rad Laboratories, Inc.,
· Sysmex Corporation,
· Miltenyi Biotec,
· II-VI Incorporated,
· Beckman Coulter, Inc. (A subsidiary of Danaher Corporation),
· Cytek Biosciences,
· bioMérieux SA,
· Q2 Solutions (a Subsidiary of IQVIA), Cytonome/ST, LLC,
· Merck KGaA,
· Sony Biotechnology Inc.,
· Cell Signaling Technology, Inc.,
· NanoCellect Biomedical,
· Apogee Flow Systems Ltd.,
Access Full Report:-
Market Analysis and Insights
North America flow cytometry market is driven by the factors such as increasing prevalence of chronic diseases, growing demand for new technologies in the flow cytometry market which enhances its demand, as well as increasing investment in research and development, which leads to market growth. Currently, healthcare expenditure has increased across developed and emerging countries which are expected to create a competitive advantage for manufacturers to develop new and innovative flow cytometry markets. However, the high cost of flow cytometry instruments is anticipated to restrain the growth of North America flow cytometry market.
Request Access for Sample Report:-
Major TOC of the Report
2 MARKET SEGMENTATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
Get TOC of the Report:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Data Bridge Market Research
Browse Related Reports@